155 related articles for article (PubMed ID: 30706535)
1. A pilot study of an integrated mental health, social and medical model for diabetes care in an inner-city setting: Three Dimensions for Diabetes (3DFD).
Ismail K; Stewart K; Ridge K; Britneff E; Freudenthal R; Stahl D; McCrone P; Gayle C; Doherty AM
Diabet Med; 2020 Oct; 37(10):1658-1668. PubMed ID: 30706535
[TBL] [Abstract][Full Text] [Related]
2. Improving quality of diabetes care by integrating psychological and social care for poorly controlled diabetes: 3 Dimensions of Care for Diabetes.
Doherty AM; Gayle C; Morgan-Jones R; Archer N; Laura-Lee ; Ismail K; Werner A
Int J Psychiatry Med; 2016; 51(1):3-15. PubMed ID: 26681232
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study.
Ismail K; Maissi E; Thomas S; Chalder T; Schmidt U; Bartlett J; Patel A; Dickens C; Creed F; Treasure J
Health Technol Assess; 2010 May; 14(22):1-101, iii-iv. PubMed ID: 20483060
[TBL] [Abstract][Full Text] [Related]
4. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial.
Warren R; Carlisle K; Mihala G; Scuffham PA
J Telemed Telecare; 2018 Oct; 24(9):586-595. PubMed ID: 28814128
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial.
Siaw MYL; Malone DC; Ko Y; Lee JY
J Clin Pharm Ther; 2018 Dec; 43(6):775-783. PubMed ID: 29696669
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
7. Mean HbA
Forbes A; Murrells T; Mulnier H; Sinclair AJ
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
[TBL] [Abstract][Full Text] [Related]
8. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of Indigenous health worker management of poorly controlled type 2 diabetes in north Queensland.
Segal L; Nguyen H; Schmidt B; Wenitong M; McDermott RA
Med J Aust; 2016 Mar; 204(5):1961e-9. PubMed ID: 26985851
[TBL] [Abstract][Full Text] [Related]
10. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study.
Azam M; Marwood L; Ismail K; Evans T; Sivaprasad S; Winkley K; Amiel SA
J Diabetes Res; 2015; 2015():587673. PubMed ID: 26090473
[TBL] [Abstract][Full Text] [Related]
12. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
[TBL] [Abstract][Full Text] [Related]
13. Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.
House A; Bryant L; Russell AM; Wright-Hughes A; Graham L; Walwyn R; Wright JM; Hulme C; O'Dwyer JL; Latchford G; Meer S; Birtwistle JC; Stansfield A; Ajjan R; Farrin A
Health Technol Assess; 2018 May; 22(26):1-328. PubMed ID: 29845932
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in an Interdisciplinary Diabetes Clinic in Rural Primary Care.
King DE; Petrone AB; Alcantara FM; Elavsky MM; Prestoza MO; Siebart J; Castelli G
South Med J; 2019 Apr; 112(4):205-209. PubMed ID: 30943537
[TBL] [Abstract][Full Text] [Related]
15. Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis.
Dijkstra RF; Niessen LW; Braspenning JC; Adang E; Grol RT
Diabet Med; 2006 Feb; 23(2):164-70. PubMed ID: 16433714
[TBL] [Abstract][Full Text] [Related]
16. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
17. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
[TBL] [Abstract][Full Text] [Related]
18. Motivational enhancement therapy with and without cognitive behaviour therapy for Type 1 diabetes: economic evaluation from a randomized controlled trial.
Patel A; Maissi E; Chang HC; Rodrigues I; Smith M; Thomas S; Chalder T; Schmidt U; Treasure J; Ismail K
Diabet Med; 2011 Apr; 28(4):470-9. PubMed ID: 21392068
[TBL] [Abstract][Full Text] [Related]
19. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized controlled study of a virtual clinic integrating primary and specialist care for patients with Type 2 diabetes mellitus.
Basudev N; Crosby-Nwaobi R; Thomas S; Chamley M; Murrells T; Forbes A
Diabet Med; 2016 Jun; 33(6):768-76. PubMed ID: 27194175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
